Page 60 - AN-2-2

Advanced Neurology Seizures and CKD

its relationship to the mechanism of action of the 1, of ethosuximide and phenobarbital by peritoneal dialysis in
5-benzodiazepine clobazam. CNS Drugs, 26: 229–244. a child. Clin Pharm, 11: 1030–1031.
https://doi.org/10.2165/11599020-000000000-00000 175. Adkins JC, Noble S, 1998, Tiagabine. A review of its
pharmacodynamic and pharmacokinetic properties and
169. Kuo CC, Lin BJ, Chang HR, et al., 2004, Use-dependent therapeutic potential in the management of epilepsy. Drugs,
inhibition of the N-methyl-D-aspartate currents by 55: 437–460.
felbamate: A gating modifier with selective binding to the
desensitized channels. Mol Pharmacol, 65: 370–380. https://doi.org/10.2165/00003495-199855030-00013
https://doi.org/10.1124/mol.65.2.370 176. Grant SM, Heel RC, 1991, Vigabatrin. A review of its
pharmacodynamic and pharmacokinetic properties, and
170. McCabe RT, Wasterlain CG, Kucharczyk NO, et al., 1993, therapeutic potential in epilepsy and disorders of motor
Evidence for anticonvulsant and neuroprotectant action control. Drugs, 41: 889–926.
of felbamate mediated by strychnine-insensitive glycine
receptors. J Pharmacol Exp Ther, 264: 1248–1252. https://doi.org/10.2165/00003495-199141060-00007
171. Sparagana SP, Strand WR, Adams RC, 2001, Felbamate 177. McLean MJ, Schmutz M, Pozza M, et al., 2005, The influence
urolithiasis. Epilepsia, 42: 682–685. of rufinamide on sodium currents and action potential firing
in rodent neurons. Epilepsia, 46: 296.
https://doi.org/10.1046/j.1528-1157.2001.32500.x
178. Rogawski MA, Hanada T, 2013, Preclinical pharmacology
172. White HS, 1999, Comparative anticonvulsant and of perampanel, a selective non‐competitive AMPA receptor
mechanistic profile of the established and newer antiepileptic antagonist. Acta Neurol Scand Suppl, 127: 19–24.
drugs. Epilepsia, 40: S2–S10.
https://doi.org/10.1111/ane.12100
https://doi.org/10.1111/j.1528-1157.1999.tb00913.x
179. Hanada T, Hashizume Y, Tokuhara N, et al., 2011,
173. Marbury TC, Lee CS, Perchalski RJ, et al., 1981, Hemodialysis Perampanel: A novel, orally active, noncompetitive AMPA‐
clearance of ethosuximide in patients with chronic renal receptor antagonist that reduces seizure activity in rodent
disease. Am J Hosp Pharm, 38: 1757–1760. models of epilepsy. Epilepsia, 52: 1331–1340.
174. Marquardt ED, Ishisaka DY, Batra KK, et al., 1992, Removal https://doi.org/10.1111/j.1528-1167.2011.03109.x

V
https://doi.org/10.36922/an.314
34
Volume 2 Issue 2 (2023) olume 2 Issue 2 (2023) 34 https://doi.org/10.36922/an.314